Cellectar Biosciences Inc (NASDAQ:CLRB)
| 1.50 Delayed Data As of 3:34pm ET |  -0.07 / -4.46%Today’s Change | 1.25 Today|||52-Week Range 7.90 | -12.28% Year-to-Date |
Latest CLRB News | Press Releases
No recent news for Cellectar Biosciences Inc.
Today’s Trading
| Previous close | 1.57 |
| Today’s open | 1.56 |
| Day’s range | 1.48 - 1.56 |
| Volume | 1,652 |
| Average volume (3 months) | 53,167 |
| Market cap | $14.7M |
Data as of 3:34pm ET, 01/31/2023
Growth & Valuation
| Earnings growth (last year) | +42.97% |
| Earnings growth (this year) | +20.19% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PULMPulmatrix Inc | -0.21 | -5.15% |
| TOVXTheriva Biologics In... | +0.03 | +3.26% |
| GLMDGalmed Pharmaceutica... | +0.05 | +8.31% |
| NRBONeurobo Pharmaceutic... | -0.01 | -1.62% |
Data as of 3:28pm ET, 01/31/2023
Financials
| Next reporting date | March 14, 2023 |
| EPS forecast (this quarter) | -$1.00 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$24.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Florham Park, New Jersey |
Forecasts
